Document Detail


Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas' disease: a marker of disease severity.
MedLine Citation:
PMID:  16226184     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: We sought to investigate whether myocardial delayed enhancement (MDE) by magnetic resonance imaging (MRI) could quantify myocardial fibrosis (MF) in patients with Chagas' heart disease (CHD), thus defining the severity of the disease. BACKGROUND: Myocardial fibrosis secondary to ischemic disease can be imaged using MDE. Advanced CHD is characterized by progressive MF. METHODS: Fifty-one patients with CHD were enrolled: 15 seropositive asymptomatic participants in the indeterminate phase (IND); 26 patients with known clinical CHD; and 10 patients with known CHD and ventricular tachycardia (VT). Using a 1.5-T MRI system, we acquired left ventricular (LV) short-axis slices using cine-MRI (LV function) and inversion-recovery gradient-echo (MDE). RESULTS: Myocardial fibrosis by MRI was present in 68.6% of all patients, in 20% of IND, 84.6% of CHD, and 100% of VT (p < 0.001). Quantified MF increased progressively across disease severity subgroups (0.9 +/- 2.3% in IND; 16.0 +/- 12.3% in CHD; and 25.4 +/- 9.8% in VT, p < 0.001) and New York Heart Association functional classes (I: 7.5 +/- 9.5%; II: 21.9 +/- 13.8%; and III: 25.3 +/- 9.9% of LV mass, p < 0.001). Left ventricular ejection fraction and MF had significant negative correlation (r = -0.78, p < 0.001), similar to the segmental MF and function: 4.9 +/- 15.1% of MF in normal function, 32.5 +/- 32.5% in mildly hypokinetic, 57.8 +/- 31.4% in severely hypokinetic, and 72.3 +/- 36.2% in akinetic and dyskinetic segments, respectively (p < 0.001). CONCLUSIONS: In CHD, MDE by MRI quantifies MF that not only can be detected in the early asymptomatic stages but parallels well-established prognostic factors and provides unique information for clinical disease staging.
Authors:
Carlos E Rochitte; Paulo F Oliveira; Joalbo M Andrade; Bárbara M Ianni; José R Parga; Luiz F Avila; Roberto Kalil-Filho; Charles Mady; José C Meneghetti; João A C Lima; José A F Ramires
Related Documents :
12918844 - Safety of dobutamine stress echocardiography in patients with aortic stenosis.
19327434 - Usefulness of two-dimensional speckle tracking echocardiography for assessment of tako-...
12804724 - Individual prediction of functional recovery after coronary revascularization in patien...
6731034 - Cardiopulmonary function in sarcoidosis.
18096834 - Medical complications in a comprehensive stroke unit and an early supported discharge s...
21640044 - Anti-citrullinated peptide antibodies and the progression of radiographic joint erosion...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2005-09-23
Journal Detail:
Title:  Journal of the American College of Cardiology     Volume:  46     ISSN:  1558-3597     ISO Abbreviation:  J. Am. Coll. Cardiol.     Publication Date:  2005 Oct 
Date Detail:
Created Date:  2005-10-17     Completed Date:  2006-01-19     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8301365     Medline TA:  J Am Coll Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1553-8     Citation Subset:  AIM; IM    
Affiliation:
Heart Institute (InCor), University of São Paulo Medical School, São Paulo, Brazil. rochitte@incor.usp.br
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Chagas Cardiomyopathy / complications,  pathology*
Female
Fibrosis
Humans
Magnetic Resonance Imaging*
Male
Myocardium / pathology
Severity of Illness Index

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Dilated-hypokinetic evolution of hypertrophic cardiomyopathy: prevalence, incidence, risk factors, a...
Next Document:  Time course of diastolic and systolic function improvement after pulmonary valve replacement in adul...